Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.

NCT07002827 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Decompensated Liver Cirrhosis

Interventions

DRUG: Darbepoetin
DRUG: G-CSF
DRUG: Lactulose
BIOLOGICAL: Albumin

Sponsor

Institute of Liver and Biliary Sciences, India